Map the Rights Before You Move the Formula

The successor plant is ready to quote, but its technical lead asks for the current formula by weight, the process sequence, the finished-product tolerances, and records from the last acceptable run. You have the bench recipe and a signed co-manufacturing agreement. The co-manufacturer has the rest in its production system. Whether you can move the product now depends on a bundle of rights and records that should have been mapped before the first commercial trial.

A formula, an improvement, a batch record, and a process instruction are not one asset. Map each right before you need to move the work.

Start With the Assets Each Side Already Has

Before scale-up, build a background IP schedule. The brand may bring the bench formula, product targets, supplier requirements, packaging specifications, test methods, and consumer research. The co-manufacturer may bring plant layouts, equipment settings, sanitation methods, general processing knowledge, software, and techniques it uses across many customers.

Do not collapse that inventory into the word “recipe.” Copyright generally does not protect a mere ingredient list, although original explanatory writing may be protected. A process improvement might raise patent questions. A formula or manufacturing method might qualify for trade-secret protection if it has the required value and is kept secret through reasonable measures. Each category carries different rules.

The agreement should identify what each side owned or controlled before the work began and what each side may continue using. That record does not create every underlying right by itself. It gives the operating team and counsel a shared map of the assets in play.

Treat Scale-Up Changes as Foreground Work

Commercial trials create new material. An ingredient ratio changes to hold texture on a larger line. A different addition sequence prevents separation. A cooling step extends the safe production window. Some changes are brand-specific, some draw on the manufacturer’s general know-how, and some combine contributions from both teams.

Keep a change log that names the problem, the people who contributed, the approved solution, the date, and the product or equipment to which it applies. Then define how rights in that foreground work should be handled. The agreement can require assignments, grant licenses, allocate filing costs, and reserve general manufacturing knowledge. It should not pretend that every improvement is legally the same kind of asset.

Patent rights can be assigned, but a broad ownership label is not a substitute for determining inventorship and completing the right documents. If a scale-up change may be patentable, have counsel identify the specific right, the intended owner, and any assignment or license needed. The answer can depend on who created the improvement, what earlier rights it uses, and the law that applies.

Specifications and Batch Records Make the Product Transferable

Owning or licensing a formula is not enough if another plant cannot reproduce the approved product. A successor needs the current master formula, ingredient and packaging specifications, approved suppliers or qualification criteria, process order, time and temperature limits, in-process checks, finished-product tolerances, test methods, and known failure modes.

Batch records show how those instructions performed in actual production. They can reveal deviations, rework, yields, lot traceability, test results, and the settings used for accepted runs. Define who creates each record, who can inspect it during the relationship, what copies the brand receives, and how corrections are documented. Waiting until termination to request years of production history turns a routine transfer into a reconstruction project.

Access and ownership are separate questions. A manufacturer may need to retain original records for its own legal and quality obligations. The brand may still need prompt access and usable copies. Write for the operational outcome instead of relying on one sentence that says all records belong to one party.

Confidentiality Has to Work on the Plant Floor

A confidentiality clause matters, but trade-secret protection also depends on how the information is handled. Identify which formulas, methods, specifications, and records are confidential. Limit access to people who need them. Mark sensitive files, control digital permissions, govern disclosure to suppliers and laboratories, and require return or destruction when access ends.

The duties should run both ways. The brand should not gain a right to reuse a co-manufacturer’s confidential platform process merely because it observed the line. The manufacturer should not reuse brand-specific confidential information for another customer merely because its team helped refine it. Employees, contractors, laboratories, and successor facilities need obligations that match the information they receive.

Secrecy controls should survive ordinary work. If the current formula travels through unrestricted email, sits in an open shared drive, or reaches vendors without confidentiality terms, the contract heading alone does not preserve a trade secret. The operating practice has to support the protection being claimed.

License Scope Determines What You Can Actually Do

The brand may not need to own every piece of manufacturing know-how. It does need enough permission to make, test, improve, and sell the product through the facilities and partners its supply plan may require. That is a license-scope question.

For each asset the brand will not own, define who may use it, for which products, in which facilities, for how long, and whether a successor manufacturer or technical consultant can receive it. Address the right to modify the material, share it for validation, and use it after termination. If the manufacturer can revoke the license, define the conditions and the effect on product already in market.

Do the same for rights the manufacturer receives. Permission to use a brand formula for production should not silently become permission to use it for development, benchmarking, or another customer. A narrow, explicit license can protect background know-how while giving the brand a practical route to continuity.

Write the Transfer Before You Need It

Transfer assistance is a deliverable, not a closing courtesy. Define the notice period, document list, file formats, response times, technical meetings, successor-plant questions, validation support, and responsibility for transfer costs. Include a way to deliver current records even when the parties are disputing invoices or winding down production.

Then test the clause against a real handoff. Could a qualified successor identify the approved inputs, reproduce the process, evaluate the output, investigate prior deviations, and know which methods it is allowed to use? If any answer depends on goodwill or an employee’s memory, the transfer plan is incomplete.

Have counsel review the specific rights, not just a generic formula-ownership clause. The review should distinguish background IP from foreground improvements, confirm any patent assignments or licenses, examine trade-secret and confidentiality controls, account for applicable state law, and make the promised access and transfer duties enforceable. The contract is a crucial part of that system. It defines obligations around the assets, but it does not make every asset the same or decide ownership in isolation.